Phathom Pharmaceuticals, Inc. (PHAT) quarterly cash flow statement — complete operating, investing & financing history
Phathom Pharmaceuticals, Inc. (PHAT) cash flow statement — 8-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -1.93M | -15.65M | -5M | -14.12M | -62.73M | -84.93M | -63.46M | -63.57M | -70.72M | -69.02M | -43.8M | -31.91M | -22.2M | -39.67M | -40.7M | -35.02M | -25.72M | -44.76M | -41.42M | -29.07M |
| Operating CF Margin % | -2.6% | -26.84% | -8.68% | -28.51% | -158.8% | -297.8% | -213.92% | -388.78% | -965.61% | -3609.83% | -6421.85% | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 96.92% | 81.58% | 92.12% | 77.8% | 11.3% | -23.05% | -44.89% | -99.2% | -218.56% | -73.99% | -7.62% | 8.86% | 13.67% | 11.37% | 1.75% | -20.47% | 9.34% | 10.06% | -46.89% | -40.23% |
| Net Income | -17.58M | -30.37M | -21.15M | -29.97M | -75.81M | -94.32M | -74.45M | -85.58M | -91.45M | -82.85M | -79.57M | -43.24M | -40.97M | -37.81M | -55.05M | -51.09M | -50.92M | -40.66M | -35.83M | -36.66M |
| Depreciation & Amortization | 114K | 110K | 128K | 156K | 172K | 177K | 193K | 191K | 197K | 214K | 185K | 121K | 123K | 146K | 168K | 175K | 149K | 128K | 135K | 130K |
| Stock-Based Compensation | 6.71M | 5.53M | 5.61M | 9.3M | 8.27M | 5.54M | 6.69M | 5.63M | 6.1M | 5.63M | 0 | 6.14M | 7.25M | 7.05M | 6.66M | 5.82M | 5.88M | 5.78M | 4.34M | 4.42M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 10.37M | 7.53M | 6.36M | 7.96M | 10.59M | 12.58M | 13.15M | 14.79M | 15.05M | 15.01M | 34.91M | 7.48M | 6.96M | 7.29M | 7.32M | 7.39M | 4.34M | 1.96M | 1.47M | 2.7M |
| Working Capital Changes | -1.54M | 1.54M | 4.05M | -1.56M | -5.95M | -8.91M | -9.04M | 1.39M | -626K | -7.02M | 676K | -2.41M | 4.43M | -16.34M | 208K | 2.69M | 14.83M | -11.95M | -11.54M | 345K |
| Change in Receivables | -16.7M | -2.6M | -22.34M | -4.53M | -14.89M | 2.43M | -17.75M | -10.18M | -7M | -2.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -3.96M | 665K | 2M | 395K | -1.85M | -12.33M | -5.58M | -418K | 268K | -416K | -9.33M | -111K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 23.4M | -3.12M | 27.57M | 1.11M | 12.38M | -6.96M | 19.94M | 11.32M | 8.69M | -5.01M | 10.27M | 4.59M | 2.86M | -11.3M | 3.92M | 1.9M | 8.94M | -6.08M | -162K | 3.23M |
| Cash from Investing | -44K | -61K | -87K | -27K | -97K | -18K | -5K | -44K | -46K | -40K | -475K | -939K | -6K | -214K | -412K | -134K | -428K | -67K | -100K | -14K |
| Capital Expenditures | 61K | -61K | 142K | -27K | -97K | -18K | -5K | 86K | -46K | -40K | -475K | -939K | -6K | -214K | -412K | -134K | -428K | -67K | -100K | -14K |
| CapEx % of Revenue | 0.08% | 0.1% | 0.25% | 0.05% | 0.25% | 0.06% | 0.02% | 0.53% | 0.63% | 2.09% | 69.65% | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -105K | 0 | -229K | 0 | 0 | 0 | 0 | -130K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.55M | 66.64M | -97K | -271K | 80K | 0 | 26.05M | 122.06M | 24.77M | 9.9M | 211.99M | 13K | 141.5M | 14.07M | 0 | 24.6M | 95.45M | 0 | 163K | 44.03M |
| Debt Issued (Net) | 0 | -55.8M | 0 | 0 | 0 | 0 | 24.75M | 0 | 24.75M | 9.9M | 211.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42.76M |
| Equity Issued (Net) | 0 | 122.56M | -373K | 293K | 80K | 0 | 0 | 121.78M | 21K | 0 | 0 | 0 | 141.39M | 14.07M | 0 | 24.6M | 0 | 0 | 0 | 1.26M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 3.55M | -128K | 276K | -564K | 0 | 0 | 1.3M | 282K | 0 | 0 | 0 | 13K | 111K | 0 | 0 | 0 | 95.45M | 0 | 163K | 0 |
| Net Change in Cash | 1.58M | 50.93M | -5.18M | -14.41M | -62.75M | -84.95M | -37.41M | 58.44M | -45.99M | -59.16M | 167.72M | -32.84M | 119.3M | -25.81M | -40.95M | -10.55M | 69.3M | -44.82M | -41.36M | 14.95M |
| Free Cash Flow | -1.87M | -15.65M | -4.89M | -14.14M | -62.73M | -84.95M | -63.46M | -63.49M | -70.77M | -69.06M | -44.27M | -32.85M | -22.21M | -39.88M | -41.11M | -35.15M | -26.14M | -44.82M | -41.52M | -29.08M |
| FCF Margin % | -2.52% | -26.84% | -8.48% | -28.57% | -158.8% | -297.86% | -213.93% | -388.25% | -966.23% | -3611.92% | -6491.5% | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 97.02% | 81.58% | 92.3% | 77.72% | 11.36% | -23.01% | -43.34% | -93.25% | -218.68% | -73.16% | -7.7% | 6.53% | 15.06% | 11.02% | 1% | -20.87% | 7.97% | 10.23% | -46.6% | -39.07% |
| FCF per Share | -0.02 | -0.19 | -0.07 | -0.19 | -0.87 | -1.18 | -0.89 | -0.98 | -1.21 | -1.18 | -0.77 | -0.58 | -0.46 | -0.94 | -1.00 | -0.91 | -0.68 | -1.18 | -1.10 | -0.78 |
| FCF Conversion (FCF/Net Income) | - | 0.52x | 0.24x | 0.47x | 0.83x | 0.90x | 0.85x | 0.74x | 0.77x | 0.83x | 0.55x | 0.74x | 0.54x | 1.05x | 0.74x | 0.69x | 0.51x | 1.10x | 1.16x | 0.79x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 4.82M | 0 | 0 | 0 | 0 | 2.91M | 0 | 2.55M | 2.1M | 0 | 1.53M | 1.39M | 1.15M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |